Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Real-World Results From an Early Access Program in Malaysia.

Ismail FB, Wahid MIA, Thiagarajan M, Tan AL, Cheah NLC, Lam KS, Chow DSY, Ang SF, Ng M, Loke H, Low JSH

DOI: 10.1111/ajco.70042
Published: 2026 Oct
Container: Asia-Pacific journal of clinical oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ajco.70042,
  title = {Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Real-World Results From an Early Access Program in Malaysia.},
  author = {Ismail FB and Wahid MIA and Thiagarajan M and Tan AL and Cheah NLC and Lam KS and Chow DSY and Ang SF and Ng M and Loke H and Low JSH},
  year = {2026},
  journal = {Asia-Pacific journal of clinical oncology},
  doi = {10.1111/ajco.70042},
  url = {https://doi.org/10.1111/ajco.70042}
}

RIS

TY  - JOUR
TI  - Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Real-World Results From an Early Access Program in Malaysia.
AU  - Ismail FB
AU  - Wahid MIA
AU  - Thiagarajan M
AU  - Tan AL
AU  - Cheah NLC
AU  - Lam KS
AU  - Chow DSY
AU  - Ang SF
AU  - Ng M
AU  - Loke H
AU  - Low JSH
PY  - 2026
JO  - Asia-Pacific journal of clinical oncology
DO  - 10.1111/ajco.70042
UR  - https://doi.org/10.1111/ajco.70042
ER  -

APA

FB, I., MIA, W., M, T., AL, T., NLC, C., KS, L., DSY, C., SF, A., M, N., H, L., & JSH, L. (2026). Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Real-World Results From an Early Access Program in Malaysia.. Asia-Pacific journal of clinical oncology. https://doi.org/10.1111/ajco.70042

Source records

pubmed · retrieved 2026-09-26T09:59:18.107Z